Tobacco use remains the leading preventable cause of disease and death in the United States.

More than half of smokers attempt to quit each year, but fewer than one in ten succeed.

Evidence-based cessation treatments, including individual, group, and telephone counseling and seven FDA-approved

credit:

How's Your Community Doing?
Check Out it's
Community Vital Signs

cessation medications, exist, but are underutilized.

The Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health is announcing the opportunity to apply for funds for a competitive, non-research cooperative agreement to provide technical assistance to state tobacco control programs and other partners to translate the science of tobacco control cessation into public health action in order to further increase the rate of cessation among tobacco users in the United States.

The funded organizations will accomplish this by providing technical assistance to state tobacco control programs and other partners to 1) Implement health systems change initiatives that seek to integrate tobacco dependence treatment into routine clinical care, including care of persons with behavioral health conditions; and 2) Improve state quitlines’ infrastructure, operations, and services to further enhance their effectiveness and efficiency, increase state quitlines’ reach, especially among populations experiencing tobacco-related disparities, broaden the range of cessation services offered by state quitlines, and enhance quitline sustainability.